GEHC · GE HealthCare Technologies Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score Cluster buy
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-22 | Lobo Kevin |
Director, Chair and CEO |
Buy↑
|
Common Stock, par value $0.01 per share
|
10,000 |
| 2026-05-15 | Rackliffe Philip |
CEO, AVS |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on May 15, 2028, and 50% will vest on May 15, 2029. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Common Stock, par value $0.01 per share
|
16,458 |
| 2026-05-15 | Bankes Jeannette |
CEO, Patient Care Solutions |
Tax↓
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. |
Common Stock, par value $0.01 per share
|
5,535 |
| 2026-05-12 | Hochman Rodney F |
Director |
Buy↑
|
Common Stock, par value $0.01 per share
(I)
|
1,618 |
| 2026-05-08 | Yang Watkin Phoebe L. |
Director |
Buy↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
Common Stock, par value $0.01 per share
|
1,000 |
| 2026-05-07 | Yang Watkin Phoebe L. |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Common Stock, par value $0.01 per share
|
3,586 |
| 2026-05-07 | CULP H LAWRENCE JR |
Director, Chairman and CEO |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan"). Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Common Stock, par value $0.01 per share
|
3,586 |
| 2026-05-07 | Lobo Kevin |
Director, Chair and CEO |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Common Stock, par value $0.01 per share
|
3,586 |
| 2026-05-07 | Madden Anne T |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election. |
Common Stock, par value $0.01 per share
|
2,282 |
| 2026-05-07 | Hochman Rodney F |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan"). Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Common Stock, par value $0.01 per share
|
3,586 |
| 2026-05-07 | LESJAK CATHERINE A |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Common Stock, par value $0.01 per share
|
3,586 |
| 2026-05-07 | Hochman Rodney F |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election. |
Common Stock, par value $0.01 per share
|
2,689 |
| 2026-05-07 | Stromberg William J |
Director, Non-Executive COB |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Common Stock, par value $0.01 per share
|
3,586 |
| 2026-05-07 | Madden Anne T |
Director |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan"). Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Common Stock, par value $0.01 per share
|
3,586 |
| 2026-05-07 | CULP H LAWRENCE JR |
Director, Chairman and CEO |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election. |
Common Stock, par value $0.01 per share
|
4,157 |
| 2026-05-06 | Stromberg William J |
Director, Non-Executive COB |
Buy↑
|
Common Stock, par value $0.01 per share
|
1,000 |
| 2026-05-06 | CULP H LAWRENCE JR |
Director, Chairman and CEO |
Buy↑
Filing footnotes — Common Stock, par value $0.01 per share (Indirect)
The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $61.50 to $62.22, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
Common Stock, par value $0.01 per share
(I)
|
80,805 |
| 2026-05-01 | SACCARO JAMES |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $60.59 to $60.60, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
Common Stock, par value $0.01 per share
|
3,310 |
| 2026-04-30 | Jimenez Frank R |
EVP and General Counsel |
Buy↑
|
Common Stock, par value $0.01 per share
|
1,750 |
| 2026-04-30 | Arduini Peter J |
Senior Vice President |
Buy↑
|
Common Stock, par value $0.01 per share
|
4,169 |
| 2026-03-13 | Lobo Kevin |
Director, Chair and CEO |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) March 13, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Common Stock, par value $0.01 per share
|
777 |
| 2026-03-13 | Lobo Kevin |
Director, Chair and CEO |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-02 | Newcomb George A. |
Chief Accounting Officer |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
Common Stock, par value $0.01 per share
|
1,309 |
| 2026-03-02 | Holton Adam Y |
Chief People Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Employee Stock Option (right to buy)
|
14,348 |
| 2026-03-02 | Jimenez Frank R |
EVP and General Counsel |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
Common Stock, par value $0.01 per share
|
10,915 |
| 2026-03-02 | Rott Roland |
CEO, Imaging |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
Common Stock, par value $0.01 per share
|
8,576 |
| 2026-03-02 | Newcomb George A. |
Chief Accounting Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Employee Stock Option (right to buy)
|
3,443 |
| 2026-03-02 | O'Neill Kevin Michael |
CEO, PDx |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Employee Stock Option (right to buy)
|
17,218 |
| 2026-03-02 | O'Neill Kevin Michael |
CEO, PDx |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
Common Stock, par value $0.01 per share
|
6,549 |
| 2026-03-02 | SACCARO JAMES |
Chief Financial Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Employee Stock Option (right to buy)
|
32,797 |
| 2026-03-02 | Rackliffe Philip |
CEO, AVS |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Employee Stock Option (right to buy)
|
24,598 |
| 2026-03-02 | Bankes Jeannette |
CEO, Patient Care Solutions |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
Common Stock, par value $0.01 per share
|
6,861 |
| 2026-03-02 | Rackliffe Philip |
CEO, AVS |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
Common Stock, par value $0.01 per share
|
9,356 |
| 2026-03-02 | Kass-Hout Taha |
Chief Technology Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Employee Stock Option (right to buy)
|
34,847 |
| 2026-03-02 | Arduini Peter J |
Senior Vice President |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
Common Stock, par value $0.01 per share
|
49,120 |
| 2026-03-02 | Rott Roland |
CEO, Imaging |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Employee Stock Option (right to buy)
|
22,548 |
| 2026-03-02 | Arduini Peter J |
Senior Vice President |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Employee Stock Option (right to buy)
|
129,140 |
| 2026-03-02 | Bankes Jeannette |
CEO, Patient Care Solutions |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Employee Stock Option (right to buy)
|
18,038 |
| 2026-03-02 | Holton Adam Y |
Chief People Officer |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
Common Stock, par value $0.01 per share
|
5,457 |
| 2026-03-02 | SACCARO JAMES |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
Common Stock, par value $0.01 per share
|
12,475 |
| 2026-03-02 | Jimenez Frank R |
EVP and General Counsel |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. |
Employee Stock Option (right to buy)
|
28,697 |
| 2026-03-02 | Kass-Hout Taha |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. |
Common Stock, par value $0.01 per share
|
13,254 |
| 2026-02-12 | Rott Roland |
CEO, Imaging |
Tax↓
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. |
Common Stock, par value $0.01 per share
|
3,943 |
| 2026-02-12 | Newcomb George A. |
Chief Accounting Officer |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. |
Common Stock, par value $0.01 per share
|
2,523 |
| 2026-02-12 | Arduini Peter J |
Senior Vice President |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. |
Common Stock, par value $0.01 per share
|
74,908 |
| 2026-02-12 | Rackliffe Philip |
CEO, AVS |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. |
Common Stock, par value $0.01 per share
|
3,154 |
| 2026-02-12 | Kass-Hout Taha |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. |
Common Stock, par value $0.01 per share
|
23,339 |
| 2026-02-12 | Kass-Hout Taha |
Chief Technology Officer |
Tax↓
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. |
Common Stock, par value $0.01 per share
|
7,787 |
| 2026-02-12 | Rackliffe Philip |
CEO, AVS |
Tax↓
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. |
Common Stock, par value $0.01 per share
|
1,174 |
| 2026-02-12 | Rott Roland |
CEO, Imaging |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. |
Common Stock, par value $0.01 per share
|
7,885 |